ABSTRACT. We used an in vitro assay to study and compare the growth-promotional activity of protein and nonprotein components in human milk (HM) and cow milk (CM) samples for infant strains of Bifidobacterium species. H M samples varied considerably in growth-promotion activity for Bifidobacterium bifidum var pennsylvanicus, Bifidobacterium infantis, and Bifidobacterium breve. Pooled CM samples showed similar but less variable levels of activity when compared with H M samples. Separation of milk samples by ultrafiltration into protein nitrogen and nonprotein nitrogen (NPN) fractions revealed that the bifidobacteria growth-promotion activity of H M was associated primarily with the NPN fraction, whereas activity in CM whey was found in both protein nitrogen and NPN fractions. Testing of purified CM whey proteins showed that a-lactalbumin and lactoferrin were potent growth promoters, showing greater activity for B. infantis and B. breve than for two strains of B. bifidum. Conversely, Nacetylglucosamine and purified gastric mucin were highly active for B. bifidum strains but inactive for other Bifidobacterium species. Collectively, the data indicate that both protein nitrogen and NPN factors in H M and CM promote the growth of bifidobacteria and suggest that Bifidobacterium species differ in responsiveness to protein and oligosaccharide growth promoters. (Pediatr Res 29: 208-213,1991) 
searchers have postulated that such differences in intestinal microflora composition may account in part for the greater resistance of breast-fed infants to enteric infection compared with formula-fed infants (6, 7) . Bifidobacteria may contribute to this protective capacity by establishing an acetate buffer in the intestinal tract of the infant (8) that may inhibit potential pathogens (9) and thus enhance natural resistance to enteric infections.
HM contains specific factors that might serve to modulate the composition of the intestinal microflora. These include numerous antiinfective components as well as specific factors that promote the growth of bifidobacteria (10) (11) (12) . Gyorgy and coworkers found that HM, but not CM, contains factors that promote the growth of B. bijidum var. pennsylvanicus (13, 14) . These factors were later identified as glycoproteins and oligosaccharides that contain NAcGlu (10, 1 1, 15, 16) . Results from other studies indicate that bifidus growth-promotion activity may also be associated with polypeptide components of HM (17) or bovine casein digest (18) . Although most of these studies have characterized bifidus growth-promotion activity by using B. bifidum var. pennsylvanicus, a relatively rare component of the intestinal microflora of the infant, the nature of growth promoters in HM and CM for the major intestinal species of bifidobacteria has not been extensively studied.
In a previous report (19) , we showed that CM was capable of promoting the growth of several human species of bifidobacteria, albeit at somewhat lower levels than HM. This activity was associated primarily with the CM whey fraction and was equal to HM whey in activity, suggesting that the lower activity of CM may be due to the lower proportion of whey to casein in CM (2090) relative to HM (70:30). Our present study further characterizes the bifidobacteria growth-promoting activity of HM and CM by comparing the activity in protein and nonprotein fractions for several common intestinal species of bifidobacteria.
MATERIALS AND METHODS

Milk samples. H M samples were obtained from 10 healthy
nursing mothers at stages of lactation ranging from 1 to 6 mo postpartum. CM samples were obtained from bulk milk tanks of eight separate farms located in Missouri, Minnesota, Nebraska, and Texas (two farms per state). Raw milk samples were frozen at -75°C until needed. Skim milk samples were prepared by centrifuging freshly thawed milk samples at 12 000 x g for 30 min and aspirating the resulting supernatant below the fat layer. ED whey was supplied by the Mead Johnson Nutritional Group (Evansville, IN). Milk and whey samples were sterilized by membrane filtration (Gelman Sciences, Inc., Ann Arbor, MI) before testing in the growth-promotion assay.
CM whey (ED whey) and HM were separated into high molecular weight and low molecular weight fractions by ultrafiltration using an Amicon model 52 (Amicon Corp., Danvers, MA) ultrafiltration cell and a YM-10 membrane (mol wt cutoff = 10 000). The initial filtrate was filter-sterilized and stored at -20°C. The initial retentate fractions (10% of original volume) of HM and CM whey were washed 10 times with saline to further 209 remove low molecular weight components and reconstituted to (ATCC 15708) . These strains were origi-assay volume for HM and CM whey, respectively). The NPN nally isolated from st001 of human infants. Stock cultures were and PN fractions were tested at the same volume used for testing grown in ~hos~hate-buffered Reinforced CIostridial Medium the initial unfractionated material to allow relative comparisons (Difco Laboratories, Detroit, MI) under anaerobic conditions of samples for growth-promotion activity. Control tubes containand maintained long-term in lyophilized form as previously ing saline in place of test samples were included in all experidescribed (1 9).
ments. Unless specifically indicated, all test samples were steriBifidobacteria growth-~romotiofi assay. The growth-promo-lized by membrane filtration (Gelman Sciences, Inc.) and tested tion activity of test samples for strains of bifidobacteria was in duplicate in at least two experiments. measured by an acid titration method (19) after growth in N o~~s Materials, BSA, a-LA, P-LG, and NAcGlu were purchased medium (22) without added HM, referred to here as basal N o~~s from Sigma Chemical CO. (St. Louis, MO), reconstituted in n~edium. Briefly, tubes containing 4 mL of rer reduced basal sterile saline, and filter-sterilized for use in growth-promotion Norris media with or without test samples were inoculated with assays. Big (Calbiochem-Behring, Sari Diego, CA) were treated test strains of bifidobacteria (about 1 X lo6 colony forming units) in a similar manner. Bovine LF (AlaPharm, Palmerston North, New Zealand) was dissolved in sterile PBS, centrifuged at 10 000 Fig. 2 . Growth-promotion activity of CM samples (1 mL/4 mL assay) for three strains of bifidobacteria. Units of activity defined in Figure 1 . The data shown represent the mean of duplicate determinations after correcting for control growth using 1 mL saline14 mL culture.
a one-way analysis of variance using Statgraphics statistical software package (STSC, Inc., Rockville, MD). Multiple comparisons were made using a multiple range test based on confidence intervals and differences between sample means. pennsylvanicus. In all subsequent experiments, acid production by 48 h was used as the marker of cell growth in the growthpromotion assay.
RESULTS
Comparison of BEfidobacteria growth in
BEfidobacteria growth-promotion activity in HM samples. Individual HM samples exhibited a high degree of variability in growth-promotion activity for B. bifidum var. pennsylvanicus, B. infantis, and B. breve (Fig. 1) . The variability in activity was greatest for B. infantis, with five HM samples showing no activity. All HM samples showed activity for B. bijidum var. pennsylvanicus and B. breve, although at varying levels. No consistent relationship was found in the level of growth-promotion activity in HM samvles for each of the three test bifidobacteria strains.
Highly active HM from a single donor (no. 88) was partitioned by membrane ultrafiltration to determine the distribution of bifidobacteria growth-promotion activity among PN and NPN compartments. Ultrafiltration was chosen as the preferred method for practical fractionation of HM with negligible loss of growth-promotion activity. As shown in Table 2 , the growthpromotion activity of HM was found primarily in the NPN fraction. The activity of HM NPN was significantly greater ( p < (Fig. 2) . Activity was highest for B. breve for all samples. Growth-promotion activity varied only slightly among different CM samples t All fractions tested at 0.24 mL/mL assay volume based on 2 mg proteinlml for CM whey.
$ Different from saline control ( p < 0.01).
3 Different from CM whey ( p < 0.01).
11 Different from CM whey ( p < 0.05). 1 Greater than saline control (p < 0.05).
Growth-promotion activity of purzjied CM whey proteins.
Because at least a portion of the bifidobacteria growth-promotion activity of CM whey appeared to be associated with whey proteins, we next compared the activity of individual CM whey proteins at various concentrations. The purity of test proteins P-LG, BSA, and BIg was 95% as claimed by the vendor and verified by PAGE (data not shown). The purity of a-LA and LF samples was estimated to be 90 and 85%, respectively, by PAGE.
Only a-LA and LF were found to promote the growth of all five test strains of bifidobacteria (Table 4 ). The growth of B. infantis and B. breve was promoted by concentrations of a-LA and LF as low as 0.25 mg/mL ( p < 0.05 versus control). B. bEfidum showed enhanced growth by a-LA and LF at concentrations of 0.5 mg/mL or higher. Both a-LA and LF were much less active for B. bijidum var. pennsylvanicus and B. longum, requiring levels of 2-4 mg/mL for growth promotion. BSA and BIg were inactive at levels as high as 4 mg/mL for B. infantis, B. breve, and both test strains of B. bijidum. P-LG was only active for B. breve and B. longum when present at relatively high concentrations (22 mg/mL).
Because individual whey proteins are normally present at different levels in CM whey (27, 28) , we also compared the activity of each whey protein at levels representing their proportional distribution in levels of CM whey (2 mg/mL) previously found to be active (Table 3) . P-LG (1.14 mg/mL), the predominant protein in CM whey, was slightly active for only B. longum, whereas a-LA (0.44 mg/mL) and LF (0.10 mg/mL) were active for B. bifidum, B. infantis, and B. breve (data not shown). BSA (0.15 mg/mL) and BIg (0.26 mg/mL) were both inactive for all test strains of bifidobacteria.
Growth response to carbohydratepromoters. NAcGlu, a known growth promoter for B. bijidum var. pennsylvanicus, and a purified oligosaccharide that contains NAcGlu (gastric mucin) were also tested for bifidobacteria growth-promotion activity. The activity of lactose was determined for comparison purposes. As shown in Figure 3 , NAcGlu (2 mg/mL) and gastric mucin (1 mg/mL) promoted the growth of B. bifidum var. pennsylvanicus and B. bifidum but were inactive for B. infantis, B. breve, and B. longum. Lactose did not promote the growth of any of the five Fig. 3 . Growth-promotion activity of NAcGlu, purified gastric mucin, and lactose for five strains of bifidobacteria. Test concentrations were as follows: NAcGlu, 2 mg/mL; gastric mucin, 1 mg/mL; lactose, 40 mg/mL. The data shown represent the means + SD from at least quadruplicate samples after correcting for control growth using 1 mL saline14 mL culture. **P < 0.01 compared with saline control.
but was typically lowest and most variable for B. bzjidum var.
pennsylvanicus.
The NPN and PN fractions from ultrafiltered CM whey, along with unfractionated CM whey, were also assayed for bifidobacteria growth-promotion activity. Both the NPN and PN fractions from CM whey contained significant growth-promotion activity for three of the five test bifidobacteria strains ( A relatively large proportion of the nitrogen in HM (about 25%) is not associated with protein and is loosely termed NPN, which comprises a heterogeneous group of low molecular weight, N-containing compounds including various oligosaccharides, glycoproteins, amino acids, peptides, urea, ammonia, and creatinine (20 We also compared the growth-promotion activity of CM samples from eight different farms in four states for three bifidobacteria strains. We chose to screen "herd milks" rather than individual CM samples to determine bifidobacteria growth-promotion activity in milk used for producing commercial milk or milkbased infant formulas, which would come from bulk milk on individual farms rather than from individual cows. Bulk CM samples showed little variation in activity for B. bijidum var. pennsylvanicus, B. infantis, and B. breve. It should be recognized however, that milk samples from individual cows may be more variable in activity for strains of bifidobacteria than milk pooled from many animals. The activity of CM whey for B. bijidum var. pennsylvanicus was found only in the NPN fraction, suggesting that N-substituted D-glucosamine residues are present and available in nonprotein components but not intact whey proteins. Growth-promotion activity for B. bijidum, B. infantis, and B. breve was present in both the whey NPN and PN fractions.
The major whey proteins in CM include ,f3-LG, a-LA, serum albumin, Ig, and LF, which collectively comprise about 90% of the protein in CM whey (27, 28) . We confirmed that whey proteins are at least partially responsible for the growth-promotion activity in CM whey by testing purified CM whey proteins. wr2A and LF, a milk protein ordinarily associated with bacteriostasis, were the two most active whey proteins, showing the greatest activity for B. infantis and B. breve. a-LA and LF were less active for B. bifidum. BIg and BSA were inactive, whereas P-LG, the major whey protein found in CM whey (27, 28) , was active at only high concentrations and only for B. longum.
In summary, we found that CM whey and HM appear to contain multiple factors that are capable of promoting the growth of intestinal strains of bifidobacteria from infants. Activity in CM whey is associated with both protein (especially a-LA and LF) and nonprotein components. The nature of the nonprotein factors in CM whey that promote the growth of bifidobacteria is not known. Our results also demonstrate that strains of bifidobacteria differ in responsiveness to growth promoters in CM depending on whether they are NAcGlu-based or protein.
NAcGlu and gastric mucin, a complex oligosaccharide that is known to contain NAcGlu, promoted significant growth of B. bijidum var. pennsylvanicus and B. bijidum, whereas whey proteins were generally poor growth promoters for these strains. Conversely, LF and a-LA served as good growth promoters for B. infantis, B. breve, and B. longum, whereas NAcGlu and gastric mucin were inactive. The well-recognized role of HM oligosaccharides as bifidobacteria growth promoters is based primarily on the response of B. bijidum var. pennsylvanicus. However, our report demonstrates that species of bifidobacteria that are commonly found in the intestinal tract of infants do not respond to NAcGlu-based promoters, underscoring the need to use clinically relevant species of bifidobacteria when studying growth-promoting factors.
